Tue, May 1, 2018
Mon, April 30, 2018
Fri, April 27, 2018
Thu, April 26, 2018
Wed, April 25, 2018
Tue, April 24, 2018
Mon, April 23, 2018
Fri, April 20, 2018
Thu, April 19, 2018
Wed, April 18, 2018
Tue, April 17, 2018
Mon, April 16, 2018

Matthew Harrison Maintained (AMGN) at Buy with Decreased Target to $200 on, Apr 25th, 2018


//stocks-investing.news-articles.net/content/201 .. th-decreased-target-to-200-on-apr-25th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Amgen Inc." (AMGN) at Buy with Decreased Target from $205 to $200 on, Apr 25th, 2018.

Matthew has made no other calls on AMGN in the last 4 months.



There are 7 other peers that have a rating on AMGN. Out of the 7 peers that are also analyzing AMGN, 5 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoff Meacham of "Barclays" Maintained at Hold with Decreased Target to $180 on, Thursday, April 5th, 2018
  • Steve Chesney of "Atlantic Equities" Downgraded from Buy to Hold on, Monday, February 5th, 2018
  • Ian Somaiya of "BMO Capital" Maintained at Hold with Increased Target to $202 on, Friday, February 2nd, 2018
  • Alethia Young of "Credit Suisse" Maintained at Hold with Increased Target to $194 on, Friday, February 2nd, 2018
  • Cory Kasimov of "JP Morgan" Maintained at Hold with Increased Target to $189 on, Wednesday, January 24th, 2018


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $190 on, Friday, February 2nd, 2018
  • David Toung of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $220 on, Tuesday, January 23rd, 2018

Publication Contributing Sources